Citalopram for Agitation in Alzheimer's Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anton Porsteinsson, MD
University of Rochester
Principal Investigator - Bruce Pollock, MD
Centre for Addiction and Mental Health
Principal Investigator - Daniel Weintraub, MD
University of Pennsylvania
Principal Investigator - Davengere Devanand, MD
Columbia University
Principal Investigator - David Shade, Esq
Johns Hopkins University
Principal Investigator - Jacobo Mintzer, MD
Medical University of South Carolina Alzheimer's Research and Clinical Programs
Principal Investigator - Jerome Yesavage, MD
Stanford University
Principal Investigator - Lon Schneider, MD
University of Southern California Keck School of Medicine Memory and Aging Center
Principal Investigator - Paul Rosenberg, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre for Addiction and Mental Health
Toronto, Ontario, Canada
- University of Southern California Keck School of Medicine Memory and Aging Center
Los Angeles, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Columbia University
New York, New York, United States
- Monroe Community Hospital
Rochester, New York, United States
- University of Pennsylvania, Section of Geriatric Psychiatry, Ralston House
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina Alzheimer'S Research and Clinical Programs
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2009
- Primary completion
- 30 Sept 2013
- Completion
- 30 Sept 2013
- Last update posted
- 27 Jun 2014
- Registered enrollment
- 186
- Registry id
- NCT00898807
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.